Incorporating Patient-Reported Outcomes in mCRC Into Shared Decision-Making

Panelists examine the value of patient-reported outcomes (PROs) in helping guide therapy selection for later-line metastatic colorectal cancer (mCRC). They stress the importance of domains such as gastrointestinal tolerability, fatigue, and functional status.

By integrating PRO data into discussions, clinicians can better align treatment strategies with patient priorities, ensuring quality of life remains central.

Systematic incorporation of PROs into routine practice can refine decision-making, helping clinicians anticipate challenges and patients feel more engaged in their care.